AMCP Position Statements

See how AMCP advocates for you. Stay informed on the latest policy actions and position statements shaping legislation and pharmacy practice so you can understand what’s changing and why it matters for your work in managed care pharmacy.

Meet the Board of Directors

Shaping Practice Standards in Managed Care Pharmacy

AMCP’s nearly 8,000 members work to improve the health of more than 200 million Americans through managed care pharmacy. Our Position Statements reflect AMCP’s stance on key professional and practice issues, guiding members in their roles and supporting advocacy with policymakers and stakeholders. Approved by the AMCP Board of Directors, these concise statements help define the responsibilities of managed care pharmacists, ensuring medications are used safely, effectively, and affordably.

Pharmacist
Legislative & Regulatory Position

ERISA and Part D Preemption

AMCP opposes attempts to erode the Employee Retirement Income Security Act (ERISA) and Medicare Part D preemption. AMCP believes that the certainty that comes with a single uniform federal standard ensures that plans subject to these laws are better able to provide access to needed medications regardless of where the patient lives or works.
Legislation & Regulation, Medicare Part D
A roll of $100 bills in between prescriptions
Legislative & Regulatory Position

Pharmaceutical Manufacturer Rebates

The rebate system is an important lever for ensuring the affordability of prescription medications and health care premiums for Americans. AMCP supports the use of a rebate system as one of many levers to help to control drug costs.
Cost-Effectiveness
Legislative & Regulatory Position

Regulation of the Prescription Drug Benefit

AMCP opposes statutory and regulatory proposals that unduly restrict the ability of pharmacists working within managed care organizations from utilizing tools and services that are essential for the management of a prescription drug benefitFind out about Regulation of the Prescription Drug Benefit.
Formulary & Utilization Management, Prior Authorization/Electronic Prior Authorization (ePA), Legislation & Regulation, Step Therapy
A prescription with money
Legislative & Regulatory Position

Competitive Marketplace

AMCP believes that a health care delivery system that is based upon a competitive marketplace will provide greater value to patients and payers than a system that is one‐size‐fits‐all that relies on centralized governmental controls and regulatory mandates.
Payment Systems, Drug Pricing
A doctor and patient
Legislative & Regulatory Position

The Best Price Requirement of the Medicaid Rebate Program

AMCP believes that to provide the greatest value to Americans who need prescription drugs, market forces must effectively ensure that manufacturers of similar drugs compete with one another to establish reasonable pricing levels and maintain consumer access to needed therapies. While government has a responsibility to protect consumers against anti-competitive activity, the government must not establish rules that have the unintended effect of undermining competition.
Payment Systems, Medicaid